We are live on ! Find out more
CNTX icon

Context Therapeutics

19 hedge funds and large institutions have $9.44M invested in Context Therapeutics in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22.24% more ownership

Funds ownership: 0%22.24% (+22%)

Holders
19
Holders Change
+19
Holders Change %
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$3.27M +$6.14M +1,230,830 New
ACM
2
AIGH Capital Management
Maryland
$2.03M +$3.8M +762,721 New
ACM
3
Altium Capital Management
New York
$1.31M +$2.46M +493,531 New
EAM
4
Empery Asset Management
New York
$954K +$1.79M +358,617 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$571K +$1.07M +214,679 New
WVP
6
Worth Venture Partners
New Jersey
$465K +$872K +174,967 New
V
7
Veritable
Delaware
$293K +$550K +110,249 New
Renaissance Technologies
8
Renaissance Technologies
New York
$172K +$322K +64,618 New
VF
9
Virtu Financial
New York
$142K +$267K +53,521 New
S
10
swisspartners
Liechtenstein
$114K +$211K +42,235 New
QC
11
QCM Cayman
Texas
$37K +$70K +14,041 New
BlackRock
12
BlackRock
New York
$31K +$57.6K +11,547 New
HF
13
HRT Financial
New York
$27K +$50.6K +10,160 New
Morgan Stanley
14
Morgan Stanley
New York
$13K +$24.9K +5,000 New
TRCT
15
Tower Research Capital (TRC)
New York
$6K +$10.2K +2,054 New
AWA
16
Amplius Wealth Advisors
Pennsylvania
$1K +$2.99K +600 New
Wells Fargo
17
Wells Fargo
California
+$165 +33 New
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
+$498 +100 New
RG
19
Retirement Group
California
+$773 +155 New

CNTX Hedge Fund Activity: Q4 2021 in Review

19 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Context Therapeutics (CNTX) for Q4 2021, worth a combined $9.44M.

Buyers outnumbered sellers: 19 funds opened new CNTX positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $6.14M.

  • 19 institutional investors held Context Therapeutics (CNTX) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $9.44M of Context Therapeutics stock for Q4 2021.
  • 19 funds opened new Context Therapeutics positions in Q4 2021 and 0 closed out, a net change of +19 holders.
  • The largest Context Therapeutics buyer in Q4 2021 was Sabby Management, an estimated $6.14M added.

Based on aggregated 13F filings for Q4 2021.